- Home
- BBIO vs BRFS Comparison
BBIO vs BRFS Comparison
Compare BBIO & BRFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BBIO
- BRFS
- Stock Information
- Founded
- BBIO 2015
- BRFS 1934
- Country
- BBIO United States
- BRFS Brazil
- Employees
- BBIO N/A
- BRFS N/A
- Industry
- BBIO Biotechnology: Pharmaceutical Preparations
- BRFS Meat/Poultry/Fish
- Sector
- BBIO Health Care
- BRFS Consumer Staples
- Exchange
- BBIO Nasdaq
- BRFS Nasdaq
- Market Cap
- BBIO 6.7B
- BRFS 5.5B
- IPO Year
- BBIO 2019
- BRFS 2000
- Fundamental
- Price
- BBIO $34.25
- BRFS $3.51
- Analyst Decision
- BBIO Strong Buy
- BRFS Hold
- Analyst Count
- BBIO 12
- BRFS 2
- Target Price
- BBIO $57.09
- BRFS $13.75
- AVG Volume (30 Days)
- BBIO 2.9M
- BRFS 5.1M
- Earning Date
- BBIO 04-29-2025
- BRFS 05-16-2025
- Dividend Yield
- BBIO N/A
- BRFS 2.85%
- EPS Growth
- BBIO N/A
- BRFS N/A
- EPS
- BBIO N/A
- BRFS 0.41
- Revenue
- BBIO $127,415,000.00
- BRFS $11,077,622,712.00
- Revenue This Year
- BBIO $89.10
- BRFS $11.01
- Revenue Next Year
- BBIO $57.07
- BRFS $4.38
- P/E Ratio
- BBIO N/A
- BRFS $8.50
- Revenue Growth
- BBIO N/A
- BRFS 18.02
- 52 Week Low
- BBIO $21.62
- BRFS $2.99
- 52 Week High
- BBIO $39.54
- BRFS $4.87
- Technical
- Relative Strength Index (RSI)
- BBIO 50.58
- BRFS 45.25
- Support Level
- BBIO $31.77
- BRFS $3.49
- Resistance Level
- BBIO $33.93
- BRFS $3.61
- Average True Range (ATR)
- BBIO 1.28
- BRFS 0.14
- MACD
- BBIO -0.09
- BRFS -0.01
- Stochastic Oscillator
- BBIO 57.14
- BRFS 33.70
About BBIO BridgeBio Pharma Inc.
BridgeBio Pharma is a biotechnology company focused on discovering, developing, testing, and delivering transformative treatments for patients with genetic diseases. The company has four programs in its late-stage pipeline focusing on Mendelian disorders, oncology, and gene therapy. One of its key programs, Attruby (acoramidis) , is an orally administered small molecule designed to stabilize tetrameric transthyretin for the treatment of transthyretin amyloid cardiomyopathy.
About BRFS BRF S.A.
BRF SA is an international producer of fresh and frozen protein foods. It operates by raising, producing, and slaughtering poultry and pork for processing, production, and sale of fresh meat, processed products, pasta, margarine, pet food, and others. The Company holds as its main brands Sadia, Perdigao, Qualy, Chester, Kidelli, Perdix, Banvit, Biofresh, and Gran Plus, present mainly in Brazil, Turkey, and Middle Eastern countries. The group has three reportable segments, being; Brazil, International, and Other segments.